Logo image
Mechanical ventilation in a dog with acetylcholinesterase inhibitor toxicosis
Journal article   Peer reviewed

Mechanical ventilation in a dog with acetylcholinesterase inhibitor toxicosis

Y.C. Tse, C.R. Sharp and T. Evans
Journal of Veterinary Emergency and Critical Care, Vol.23(4), pp.442-446
2013
url
Link to Published Version *Subscription may be requiredView

Abstract

Background To describe a case of acetylcholinesterase inhibitor (AChEI) toxicosis with ventilatory failure that was successfully treated with mechanical ventilation (MV). Key Findings A 7‐year‐old, female spayed German Short‐haired Pointer, presented with acute onset ptyalism, generalized muscle tremors, and diarrhea. Physical examination findings included evidence of muscarinic overstimulation in the parasympathetic nervous system (eg, diarrhea, ptyalism, lacrimation), and nicotinic overstimulation in the sympathetic nervous system (tachycardia), central nervous system (agitation), and the neuromuscular junction (eg, diffuse muscle fasciculations, tetraparesis). Point‐of‐care testing demonstrated hyperlactatemic metabolic acidosis and respiratory acidosis (hypoventilation). Hypoventilation progressed to respiratory failure and the dog lost its gag reflex necessitating emergency endotracheal intubation and MV. Additional treatments included atropine, parenteral antimicrobials (for aspiration pneumonia), pralidoxime, and supportive care. Weaning from the ventilator was achieved in 4 days. The dog was administered supplemental oxygen for 24 hours, and discharged 48 hours later with improved neurologic function and normal respiratory drive. Whole blood acetylcholinesterase activities measured on day 0, 2, and 4 and were consistent with AChEI toxicity. New or Unique Information Provided Specific AChEI toxicity (ie, carbamate and organophosphate) has been reported in the veterinary literature with good prognosis for survival and hospital discharge. While the existing veterinary literature suggests that ventilatory failure is rare in this disease syndrome, consideration for treatment with MV must be made for patients that develop respiratory failure (associated with hypoventilation, bronchoconstriction, bronchorrhea, or aspiration pneumonia).

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
3 Agriculture, Environment & Ecology
3.60 Herbicides, Pesticides & Ground Poisoning
3.60.548 Cholinesterase Inhibition
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image